share_log

阿里健康:截至2024年2月29日之股份發行人的證券變動月報表

ALI HEALTH: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024

香港交易所 ·  Mar 5 02:30
Summary by Moomoo AI
阿里健康信息技術有限公司於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的公司股本變動情況。報告顯示,公司的法定/註冊股本及已發行股份在報告期內保持不變,普通股股份結存總數為20,000,000,000股,每股面值0.01港元,總股本為200,000,000港元。此外,公司股份期權計劃下,本月內有604,531股份期權失效,使得本月底結存的股份期權數目為26,462,744股。根據股份獎勵計劃,公司於不同時間授出的受限制股份單位均無本月內變動。報告亦確認,所有證券發行均已獲得董事會正式授權批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
阿里健康信息技術有限公司於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的公司股本變動情況。報告顯示,公司的法定/註冊股本及已發行股份在報告期內保持不變,普通股股份結存總數為20,000,000,000股,每股面值0.01港元,總股本為200,000,000港元。此外,公司股份期權計劃下,本月內有604,531股份期權失效,使得本月底結存的股份期權數目為26,462,744股。根據股份獎勵計劃,公司於不同時間授出的受限制股份單位均無本月內變動。報告亦確認,所有證券發行均已獲得董事會正式授權批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
Ali Health Information Technology Limited filed with Hong Kong Trading and Settlement Limited on 5 March 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's share capital as of 29 February 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the reporting period. The total number of ordinary shares outstanding was 20,000,000,000 shares with a face value of HK$0.01 per share and a total share capital of HK$200,000,000. In addition, 604,531 share options expired this month under the company's stock option plan, bringing the total number of options outstanding at the end of the month to 26,462,744 shares. Under the Share Award Scheme, the Company's units of restricted shares granted at different times were unchanged during the month. The report also confirms that all securities issues have been formally authorised by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Ali Health Information Technology Limited filed with Hong Kong Trading and Settlement Limited on 5 March 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's share capital as of 29 February 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the reporting period. The total number of ordinary shares outstanding was 20,000,000,000 shares with a face value of HK$0.01 per share and a total share capital of HK$200,000,000. In addition, 604,531 share options expired this month under the company's stock option plan, bringing the total number of options outstanding at the end of the month to 26,462,744 shares. Under the Share Award Scheme, the Company's units of restricted shares granted at different times were unchanged during the month. The report also confirms that all securities issues have been formally authorised by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more